XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.3Close
CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Thousands, $ in Millions
Sep. 30, 2023
Sep. 24, 2022
Current assets:    
Cash and cash equivalents $ 29,965 $ 23,646
Marketable securities 31,590 24,658
Accounts receivable, net 29,508 28,184
Vendor non-trade receivables 31,477 32,748
Inventories 6,331 4,946
Other current assets 14,695 21,223
Total current assets 143,566 135,405
Non-current assets:    
Marketable securities 100,544 120,805
Property, plant and equipment, net 43,715 42,117
Other non-current assets 64,758 54,428
Total non-current assets 209,017 217,350
Total assets 352,583 352,755 Close
Current liabilities:    
Accounts payable 62,611 64,115
Other current liabilities 58,829 60,845
Deferred revenue 8,061 7,912
Commercial paper 5,985 9,982
Term debt 9,822 11,128
Total current liabilities 145,308 153,982
Non-current liabilities:    
Term debt 95,281 98,959
Other non-current liabilities 49,848 49,142
Total non-current liabilities 145,129 148,101
Total liabilities 290,437 302,083 Close
Commitments and contingencies
Common stock, shares outstanding (in shares) 15,550,061 15,943,425 Close
Common stock, shares issued (in shares) 15,550,061 15,943,425
Shareholders’ equity:    
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,550,061 and 15,943,425 shares issued and outstanding, respectively $ 73,812 $ 64,849
Accumulated deficit (214) (3,068)
Accumulated other comprehensive loss (11,452) (11,109)
Total shareholders’ equity 62,146 50,672 Close
Total liabilities and shareholders’ equity $ 352,583 $ 352,755